Company intelligence / Profile preview

molim

Suwon-si, Gyeonggi-do, South Korea

Ownership: Private
Employees: ~29
Development stage: Other

Overview

molim is a South Korea-based biotech company specializing in molecular imaging technologies to accelerate and enhance the accuracy of new drug development. The company's advanced imaging techniques support pharmaceutical R&D by providing critical data for preclinical and clinical studies[1].

Modalities: Molecular imaging technology
Industry: Drug Discovery Services

Beyond the preview

Go deeper on molim.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on molim.

Explore the full profile